A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Lorenz, Katrin

A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. [electronic resource] - Trials 03 2017 - 128 p. digital

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1745-6215

10.1186/s13063-017-1861-3 doi


Administration, Ophthalmic
Angiogenesis Inhibitors--administration & dosage
Clinical Protocols
Double-Blind Method
Europe
Glaucoma, Neovascular--etiology
Gonioscopy
Humans
Insulin Receptor Substrate Proteins--genetics
Intraocular Pressure--drug effects
Neovascularization, Pathologic
Oligonucleotides--administration & dosage
Ophthalmic Solutions
Prospective Studies
Research Design
Retinal Neovascularization--etiology
Retinal Vein Occlusion--complications
Signal Transduction--drug effects
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha--metabolism
Vascular Endothelial Growth Factor A--metabolism